Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Medical Hypotheses|January 9, 1998
Short note: can depressive patients exploit the immune system for suicide?S Mendlovic, A Doron, E EilatImmunobiology|December 29, 2000
A peptide based on the CDR1 of a pathogenic anti-DNA antibody is more efficient than its analogs in inhibiting autoreactive T cellsE Eilat, M Fridkin, E MozesProceedings of the National Academy of Sciences of the United States of America|February 7, 2001
The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosusE Eilat, M Dayan, H Zinger, et al.Journal of Clinical Immunology|August 12, 2000
Prevention of systemic lupus erythematosus-like disease in (NZBxNZW)F1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic autoantibodyE Eilat, H Zinger, A Nyska, et al.Immunology|February 26, 2000
Characterization and role in experimental systemic lupus erythematosus of T-cell lines specific to peptides based on complementarity-determining region-1 and complementarity-determining region-3 of a pathogenic anti-DNA monoclonal antibodyN Brosh, E Eilat, H Zinger, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Increased apoptosis in patients with major depression: A preliminary studyE Eilat, S Mendlovic, A Doron, et al.Suicide & Life-Threatening Behavior|November 10, 1998
Physiological reactions to a suicide film: suicide attempters, suicide ideators, and nonsuicidal patientsA Doron, D Stein, Y Levine, et al.Acta Obstetricia Et Gynecologica Scandinavica|August 1, 1996
Hysteroscopy is superior to hysterosalpingography in infertility investigationA Golan, E Eilat, R Ron-El, et al.Immunology Letters|May 8, 1999
Immune activation in non-treated suicidal major depressionS Mendlovic, E Mozes, E Eilat, et al.Proceedings of the National Academy of Sciences of the United States of America|April 29, 1997
Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibodyA Waisman, P J Ruiz, E Israeli, et al.Pageof 2